region, often grows in cultivated fields where its seeds, containing AA, commingle with wheat grain during the annual harvest. As bread, the dietary staple of the region, is prepared traditionally from flour made from locally-grown wheat, residents of the endemic region consuming homebaked bread may be exposed, over time, to toxic amounts of AA [4, 5] .
In 1993 Vanherweghem et al reported in the Lancet an outbreak of a rapidly progressive tubulointerstital kidney disease in Belgian women who had followed the same slimming regimen in the same medical clinic in Brussels [6] . Since 1990 the prescribed slimming pills contained two herbs imported from China and therefore the disease was initially designated as 'Chinese herbs nephropathy' (CHN). Although in the original paper it was mentioned that AA could not be found in the slimming pills, later investigations clearly showed the pills contained AA, probably because one of the prescribed herbs, Stephania tetrandra ('Han Fang-ji'), was inadvertently substituted by Aristolochia fangchi ('Guang Fang-ji') [7] . The detection of AA-specific DNA adducts in kidney and urinary tract tissues from patients with CHN unambiguously demonstrated exposure to AA [8] [9] [10] [11] . Moreover, it provided the pathophysiologic clue as to the cause of the urothelial malignancies seen in a substantial part of these patients. Indeed, the 7-(deoxyadenosine-N 6 -yl)-aristolactam I adduct (dA-AAI) is a premutagenic lesion and is associated with mutations in genes involved in carcinogenesis such as the H-ras protooncogene and the p53 tumour-suppressor gene. In addition, rodents given AA developed similar clinical features, renal interstitial fibrosis and urothelial atypia as CHN patients, demonstrating the central role of AA in the pathogenesis of CHN [7] .
From the very beginning it was obvious that both the clinical presentation and the histological findings of the now-called aristolochic acid nephropathy (AAN) are very similar to those observed in BEN (Table 1 ) [12] . This observation raised the possibility of a common cause for both diseases: AA. A pilot study in three patients living in the endemic region (two urothelial malignancies and one uretral stenosis) indeed showed dA-AAI adducts in kidney tissue in two out of three patients [13] . However, it was not clear whether these patients were actually suffering from BEN. In the July issue of PNAS Grollman and colleagues presented strong evidence that AA is indeed the cause of BEN and the associated urothelial malignancies [14] . Using a 32 P-postlabeling/polyacrylamide gel electrophoresis technique, the authors identified the AA-derived DNA adducts dA-aristolactam (AL) and dG-AL in the renal cortex of four patients with BEN, but not in five patients with other chronic renal diseases or five patients with upper urinary tract malignancies living in non-endemic regions, for the first time proving AA exposure in BEN patients. Furthermore, dA-AL and dG-AL were detected in upper urinary tract malignancies of three long-term residents of endemic villages. The authors went further, delving into the mutational background of the urothelial malignancies. DNA was isolated from tumour tissue from 11 patients who had resided in endemic villages for at least 15 years and exons 2-11 of the tumour-suppressor gene p53 were sequenced. Nineteen base substitutions were identified. Importantly, mutations at A:T pairs accounted for 89% of all p53 mutations, with 78% of these being A:T → T:A transversions. This mutational 'fingerprint' is also seen in cultured cells and in rodents treated with AA [15] . Of note, histopathologic analyses of the renal cortex of these patients showed changes that were diagnostic or highly suggestive of BEN in eight out of nine patients (insufficient tissue in two patients).
That AA produced by A. clematitis is the cause of BEN is an old hypothesis, which was more recently supported by the research in AAN. However, Grollman et al are the first to provide 'direct' instead of 'circumstantial' evidence that AA is indeed the 'culprit' of BEN. Furthermore, they provide some true mechanistic insights into how exposure to AA can cause the associated urothelial malignancies. Two major questions remain to be explored. First, it is currently unclear why only 2-5% of the people living in the endemic regions is affected by the disease, although a substantially larger number of individuals is likely to have been exposed to toxic amounts of AA. A large genetic component in the susceptibility to the disease has been suggested, but further research is warranted. Second, the proposed way of exposure, although plausible, remains to be proven by the detection of AA in flour and bread from the endemic region, which might be impossible given the presumably very low concentrations of AA in these products. The good news, however, is that if the AA hypothesis holds true, we can expect the incidence of BEN and the associated urothelial tumours to decrease over the years to come, because both agricultural developments (i.e. introduction of herbicides, new harvesting techniques) and lifestyle changes (i.e. diminished daily intake of bread, fewer families baking their own bread) will most likely lead to a decrease in dietary exposure to AA. In the meantime public health authorities in the affected countries should implement measures to remove the potential source of AA from contaminated grain, like some countries banned the use of herbs containing AA following the Chinese herbs disaster in Belgium [16] .
